Results 271 to 280 of about 18,835 (320)

Therapeutic Equivalency of Low-Molecular-Weight Heparins

open access: closedAnnals of Pharmacotherapy, 2002
OBJECTIVE: To review the recent literature on the approved uses of enoxaparin, dalteparin, ardeparin, and tinzaparin and the evidence for therapeutic equivalence. DATA SOURCES: A MEDLINE search (1993–January 2001) was conducted to identify English-language literature available on enoxaparin, dalteparin, ardeparin, and tinzaparin.
Gary M, McCart, Steven R, Kayser
openaire   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Understanding Therapeutic Equivalence in Epilepsy

CNS Spectrums, 2010
ABSTRACTThe issues surrounding generic drug substitution in patients with epilepsy are complex.The substitution of one formulation of an antiepileptic drug (AED) for another is controversial. Well-reasoned and defensible cases can be made both for and against such substitution.
Raman, Sankar, Tracy A, Glauser
openaire   +2 more sources

The therapeutic equivalence of complex drugs

Regulatory Toxicology and Pharmacology, 2011
When the patent of a small molecule drug expires generics may be introduced. They are considered therapeutically equivalent once pharmaceutical equivalence (i.e. identical active substances) and bioequivalence (i.e. comparable pharmacokinetics) have been established in a cross-over volunteer study.
Schellekens, Huub   +5 more
openaire   +5 more sources

Therapeutic equivalency of two lidocaine preparations

American Journal of Health-System Pharmacy, 1976
Twenty-five volunteers were studied as to the onset and duration of action of two commercial brands of lidocaine. One and two percent concentrations of the preparations were tested intradermally using a double-blind, cross-over protocol. Both needle-drop and electrical stimulation techniques were employed as the source of pain stimulus. Five additional
J E, Stambaugh   +2 more
openaire   +2 more sources

GENERIC DRUGS AND THERAPEUTIC EQUIVALENCE

JAMA: The Journal of the American Medical Association, 1968
In recent years, there has developed the belief that nonproprietary or generic drugs are much cheaper than, and as effective as, trade-named items. This belief has led to a widespread demand that prescribing and use of generic drugs be encouraged. Studies conducted by impartial groups such as the Medical Letter on Drugs and Therapeutics have applied ...
openaire   +2 more sources

Therapeutic equivalence: fallacies and falsification

Statistics in Medicine, 2003
AbstractThe number of studies designed specifically to demonstrate therapeutic equivalence or alternatively non‐inferiority of pharmaceutical treatments has increased dramatically in recent years, during which time awareness of the methodological issues has increased. Regulatory authorities have been quick to recognize the need for specific support and
openaire   +2 more sources

Therapeutic equivalence investigations: statistical considerations

Statistics in Medicine, 1998
Therapeutic equivalence studies still present problems to regulatory reviewers from many perspectives. This paper is intended to discuss some of these concerns from the statistical viewpoint. There are, however, also some newer approaches which may be particularly useful for the investigation of therapeutic equivalence.
openaire   +2 more sources

Therapeutic equivalency of procainamide—A correction

open access: closedThe American Journal of Cardiology, 1991
Blair P. Grubb
openaire   +2 more sources

Home - About - Disclaimer - Privacy